BillionToOne vs Natera
BLLN and NTRA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BLLN and NTRA compare
Natera is the larger company, worth 11 times as much as BillionToOne ($59.7B against $5.3B).
BillionToOne grew revenue faster over the last twelve months (90.1% versus 37.8% for Natera).
BillionToOne keeps more of each dollar of sales as profit, with a net margin of 9.5% compared with −7.1% at Natera.
BillionToOne scores higher on the StockData Score (11 against 10 for Natera), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BLLN | NTRA |
|---|---|---|
| Size and price | ||
| Market cap | $5.3B | $59.7B |
| Share price | $113.32 | $414.30 |
| Change, 1 year | – | 115% |
| Change, 5 years | – | 257% |
| Beta (5Y) | – | 1.34 |
| Employees | 713 | 6,140 |
| StockData Score | ||
| Total score | 11 (better) | 10 |
| Valuation score | 0 | 0 |
| Growth score | 3 | 3 |
| Performance score | 2 | 2 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 13.5× (better) | 22.1× |
| P/B | 10.0× (better) | 32.8× |
| EV/EBITDA | 95.5× | – |
| P/FCF | 161× (better) | 709× |
| FCF yield | 0.62% (better) | 0.14% |
| Fair value | – | $124.09 |
| Margin of safety | – | −234% |
| Growth | ||
| Revenue growth (TTM) | 90.1% (better) | 37.8% |
| Revenue growth, 5Y average | – | 42.6% |
| Profitability | ||
| Gross margin | 71.3% | – |
| Operating margin | 10.9% (better) | −10.7% |
| Net margin | 9.5% (better) | −7.1% |
| FCF margin | 8.3% (better) | 3.1% |
| Return on equity | 26.5% (better) | −12.5% |
| Return on invested capital | – | −40.8% |
| Financial health | ||
| Debt / equity | 0.00 | 0.04 (better) |
| Interest coverage | 1056× (better) | −75.9× |
| Current ratio | 11.69 (better) | 3.00 |
| Altman Z-score | 17.88 | 42.48 (better) |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 32.4% | 95.2% |
| Held by insiders | 55.4% | 4.0% |
| Insider net buying, 12 months | −$42.8M (better) | −$371M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 13.4% | 4.6% |
Go deeper
- BLLN stock overview
- BLLN income statement
- BLLN valuation and score
- NTRA stock overview
- NTRA income statement
- NTRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.